NCT02638220

Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 442 (actual)
• Sponsor: Travere Therapeutics, Inc. · Industry
• Sex: All
• Age: 2 Years – 21 Years
• Healthy volunteers: Not accepted

Summary

Iiopathic bilateral cataracts occur in many children with Cerebrotendinous Xanthomatosis (CTX) so the opportunity to use contact with health care providers in connection with pediatric cataract evaluation and treatment is a promising avenue for disease detection and prevention.

Detailed description

This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that site's initiation, or by entering care at the site while the site is participating in the trial.

Conditions

• Cerebrotendinous Xanthomatosis (CTX)

Timeline

• Start date: 2015-09-01
• Primary completion: 2021-02-19
• Completion: 2021-02-19
• First posted: 2015-12-23
• Last updated: 2024-09-19
• Results posted: 2024-09-19

Locations

44 sites across 1 country: United States